OpenVSafe by OpenVAERS
Search V-safe

GJE-26078-93349

2 vaccinations 2 coded responses 16 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
31-35
ZIP prefix
970 / OR
Registered
2021-12-21
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-11-30
    Dose 1 — Pfizer-BioNTech
  2. 2021-12-21
    Registered in v-safe
  3. 2021-12-21
    Dose 2 — Pfizer-BioNTech
  4. 2021-12-21
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Redness, Itching · None
    Adult check-in
  5. 2021-12-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  6. 2021-12-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  7. 2021-12-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  8. 2021-12-25
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  9. 2021-12-26
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  10. 2021-12-27
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-12-28
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  12. 2022-01-04
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  13. 2022-01-11
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  14. 2022-01-19
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  15. 2022-01-26
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  16. 2022-02-01
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  17. 2022-03-22
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  18. 2022-06-21
    Survey response — 6 months, dose 2
    MedDRA: Pregnancy — Feeling: Good
    Free text: Pregnant
    MedDRA releases: 2024-11 · check-in free text available
  19. 2022-12-23
    Survey response — 12 months, dose 2
    MedDRA: COVID-19, Influenza — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: Influenza a and Covid
    MedDRA releases: 2024-11 · check-in free text available
  20. 2022-12-23
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
  21. 2022-12-27

Vaccinations

DoseDateManufacturerCo-administered
12021-11-30Pfizer-BioNTech No
22021-12-21Pfizer-BioNTech No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 12 — 6 months, dose 2

2022-06-21

Symptoms: Pregnant

Release 12 — 12 months, dose 2

2022-12-23

Symptoms: Influenza a and Covid

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCOVID-19 · · ✓
SDInfluenza · · ✓
SDPregnancy · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…